olivLaw · European equity research
Koninklijke Philips N.V. PHIA.AS
Netherlands · Euronext Amsterdam · ISIN NL0000009538 · Vertical: Listed companies from Netherlands
At the close of 06 Nov 2026, Koninklijke Philips N.V. (PHIA.AS) stock was 27.33 EUR (−0.65% on the day), with market capitalisation 26.0 bn EUR, P/E 29.4 on diluted EPS of 0.93 EUR over the last 12 months, dividend yield 3.11%, beta 0.81, 52-week range 21.14–27.57 EUR.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 84.5
- overbought (≥ 70)
- Bollinger (20, 2)
- 20.83 – 27.41
- in the upper half of the band · %B 0.99 · band width 27.3%
- SMA 50 / 200
- 22.75 / 23.58
- mixed trend
- MACD (12, 26, 9)
- 1.21 / 0.81
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +26.9% | −0.2% | +27.1 pp | — |
| 3 months | +18.2% | −5.4% | +23.6 pp | — |
| 6 months | +18.2% | +4.4% | +13.8 pp | — |
| Year to date | +17.6% | +6.5% | +11.1 pp | — |
| 1 year | +11.8% | +10.0% | +1.9 pp | −2.4% |
| 3 years | +50.0% | +48.6% | +1.4 pp | +0.3% |
| 5 years | −28.5% | +41.4% | −69.9 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 100 percentile of its own 1-quarter history (min 25.0, median 25.0, max 25.0; quarters with earnings only).
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 17.8 bn | 18.2 bn | 18.0 bn | 17.8 bn |
| Revenue YoY | unavailable | +1.9% | −0.8% | −1.0% |
| Net income | -1.6 bn | -466.0 m | -702.0 m | 895.0 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | -1.69 | -0.49 | -0.75 | 0.93 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable |
| net % | -9.0% | -2.6% | -3.9% | 5.0% |
| Free cash flow | unavailable | unavailable | unavailable | unavailable |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 2.8 bn EUR
- Financial debt
- 6.9 bn EUR
- Net debt
- 4.1 bn EUR
- Equity
- 11.0 bn EUR
- Total assets
- 26.9 bn EUR
- Debt / equity
- 0.63x
- Current ratio
- 1.32x
- ROE
- 7.8%
- ROA
- 3.2%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (EUR)
Margins
Income statement · EUR
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Revenue | 17.8 bn | 18.2 bn | 18.0 bn | 17.8 bn | esef· 04 Mar 2026verified |
| Cost of revenue | 10.6 bn | 10.7 bn | 10.2 bn | 9.8 bn | esef· 04 Mar 2026verified |
| Gross profit | 7.2 bn | 7.4 bn | 7.8 bn | 8.1 bn | esef· 04 Mar 2026verified |
| Research & development | 2.1 bn | 1.9 bn | 1.7 bn | 1.7 bn | esef· 04 Mar 2026verified |
| Operating income | -1.5 bn | -115.0 m | 529.0 m | 1.4 bn | esef· 04 Mar 2026verified |
| Interest expense | 258.0 m | 376.0 m | 387.0 m | 346.0 m | esef· 04 Mar 2026verified |
| Pre-tax income | -1.7 bn | -526.0 m | 123.0 m | 1.2 bn | esef· 04 Mar 2026verified |
| Income tax | -113.0 m | -73.0 m | 963.0 m | 282.0 m | esef· 04 Mar 2026verified |
| Net income | -1.6 bn | -466.0 m | -702.0 m | 895.0 m | esef· 04 Mar 2026verified |
| Diluted EPS | -1.69 | -0.49 | -0.75 | 0.93 | esef· 04 Mar 2026verified |
| Dividend per share | 0.85 | 0.85 | 0.85 | 0.85 | esef· 04 Mar 2026verified |
Balance sheet · EUR
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Cash | 1.2 bn | 1.9 bn | 2.4 bn | 2.8 bn | esef· 04 Mar 2026verified |
| Receivables | — | 3.7 bn | 3.7 bn | 3.5 bn | esef· 04 Mar 2026verified |
| Inventories | — | 3.5 bn | 3.2 bn | 2.9 bn | esef· 04 Mar 2026verified |
| Current assets | — | 9.9 bn | 10.0 bn | 9.9 bn | esef· 04 Mar 2026verified |
| Goodwill | — | 9.9 bn | 10.4 bn | 9.3 bn | esef· 04 Mar 2026verified |
| Intangibles (excl. goodwill) | — | 3.2 bn | 3.0 bn | 2.6 bn | esef· 04 Mar 2026verified |
| Total assets | — | 29.4 bn | 29.0 bn | 26.9 bn | esef· 04 Mar 2026verified |
| Accounts payable | — | 1.9 bn | 1.8 bn | 1.9 bn | esef· 04 Mar 2026verified |
| Long-term debt | — | 7.0 bn | 7.1 bn | 6.9 bn | esef· 04 Mar 2026verified |
| Current liabilities | — | 8.3 bn | 8.1 bn | 7.5 bn | esef· 04 Mar 2026verified |
| Total liabilities | — | 17.3 bn | 16.9 bn | 16.0 bn | esef· 04 Mar 2026verified |
| Equity | 13.3 bn | 12.1 bn | 12.0 bn | 11.0 bn | esef· 04 Mar 2026verified |
| Shares outstanding at year end | 951.5 m | 951.0 m | 936.0 m | 952.1 m | esef· 04 Mar 2026derived |
Cash flow · EUR
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 52.1% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
06 Nov 2026Source: olivLaw, closing series
Market cap: 26.0 bn EUR
Key indicators
Coverage and freshness
Score by group
52% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 9.79 – 23.53 EUR.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (EUR per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E9.79 – 23.53 (Mid 13.40)16 companies used · median multiple 14.4x · quartiles 10.5x – 25.3xAALB.AS, ACOMO.AS, AD.AS, ADYEN.AS, AKZA.AS, ARCAD.AS, ASM.AS, ASML.AS, AXS.AS, BAMNB.AS, BNJ.AS, CRBN.AS, CTAC.AS, ECMPA.AS, FFARM.AS, HAL.AS
- Dividend discount (DDM)11.56 – 15.76 (Mid 13.34)
Assumptions (illustrative, editorial)
- Risk-free rate
- 3.0%
- Equity risk premium
- 5.5%
- Beta (default)
- 1.00
- Cost of equity
- 8.5%
- Terminal growth
- 2.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 52.1% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 6.8% | 50 (vs peers) | 20% |
| Net margin · Quality | 5.0% | 67 (vs peers) | 12% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | 0.0% | 0 (on a fixed band) | 16% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 4.1x | 40 (on a fixed band) | 12% |
| Current ratio · Balance sheet | 1.3x | 44 (on a fixed band) | 8% |
| P/E (TTM) · Valuation | 29.4x | 38 (vs peers) | 20% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | 0.0% | 0 (on a fixed band) | 12% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet42/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality56/100 · 2/3 factors with a value
- Returns· partial0/100 · 1/2 factors with a value
- Valuation· partial38/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Koninklijke Philips N.V. (PHIA.AS). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 17.8 bn EUR in 2025; YoY growth -1.0%; net margin 5.0%; ROE 7.8%.
The estimated value range is 10.68–19.65 EUR per share (median of 2 methods, agreement: high); assumptions are illustrative. Against the central value of 13.37 EUR, the price of 27.33 EUR leaves a potential of -51.1% (value / price − 1) and a margin of safety of -104.4% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 52.1% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
What contradicts it
- Revenue CAGR 3Y: 0.0%
- Shareholder yield (distributions): 0.0%
- The price is above the estimated value range
Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, FCF yield, Payout ratio (FCF).
Versus the vertical median
Listed companies from Netherlands · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ASML.ASASML Holding N.V. | 498.6 bn | 48.9 | 44.2% | 31.3% | +15.6% | +42% / +106% |
| DSFIR.ASDSM-Firmenich AG | 32.7 bn | 116.8 | 1.2% | 2.2% | +20.4% | +55% / +26% |
| ASM.ASASM International N.V. | 31.9 bn | 44.3 | 18.7% | 22.8% | +8.2% | +37% / +38% |
| AD.ASKoninklijke Ahold Delhaize N.V. | 30.9 bn | 13.7 | 15.3% | 2.5% | +3.4% | −4% / +29% |
| ADYEN.ASAdyen N.V. | 28.4 bn | 26.8 | 22.3% | 40.1% | +18.9% | −33% / −16% |
| PHIA.ASKoninklijke Philips N.V. | 26.0 bn | 29.4 | 7.8% | 5.0% | −1.0% | +13% / +51% |
| HAL.ASHAL Trust | 15.3 bn | 9.6 | 10.5% | 12.8% | +1.2% | +21% / +46% |
| EXO.ASExor N.V. | 15.1 bn | — | -10.6% | — | −100.0% | +1% / −18% |
| BESI.ASBE Semiconductor Industries N.V. | 11.4 bn | 86.4 | 28.7% | 22.3% | −2.7% | +10% / +12% |
| AKZA.ASAkzo Nobel N.V. | 10.8 bn | 17.0 | 13.8% | 6.3% | −5.2% | +12% / −11% |
| AALB.ASAalberts N.V. | 4.4 bn | 24.8 | 7.2% | 5.7% | −5.3% | +45% / +11% |
| ARCAD.ASArcadis N.V. | 4.1 bn | 19.8 | 18.3% | 4.3% | −2.4% | +21% / +0% |
| BNJ.ASBanijay Group N.V. | 3.4 bn | 13.8 | 343.8% | 5.1% | +1.6% | −11% / −8% |
| BAMNB.ASKoninklijke BAM Groep N.V. | 3.3 bn | 42.0 | 9.1% | 1.3% | +2.9% | +47% / +403% |
| BFIT.ASBasic-Fit N.V. | 2.0 bn | 137.1 | 3.6% | 1.0% | +16.9% | +6% / +15% |
| CRBN.ASCorbion N.V. | 1.6 bn | 8.3 | 27.3% | 14.9% | +1.9% | +39% / +55% |
| ECMPA.ASEurocommercial Properties N.V. | 1.4 bn | 11.2 | 5.9% | 45.4% | +4.2% | −4% / +19% |
| FUR.ASFugro N.V. | 963.7 m | — | -1.5% | -1.1% | −18.8% | −2% / −50% |
| ACOMO.ASAcomo N.V. | 681.5 m | 15.1 | 10.7% | 3.3% | +7.6% | −4% / +36% |
| FAST.ASFastned B.V. | 671.8 m | — | -28.2% | -21.7% | +66.1% | +62% / +26% |
| FFARM.ASForFarmers N.V. | 477.6 m | 9.6 | 14.5% | 1.6% | +14.8% | +21% / +122% |
| BRNL.ASBrunel International N.V. | 356.7 m | 116.8 | 1.0% | 0.3% | −10.8% | −12% / −34% |
| ALFEN.ASAlfen N.V. | 222.6 m | — | -0.1% | -0.0% | −10.7% | −3% / −78% |
| ENVI.ASEnvipco Holding N.V. | 219.9 m | — | -12.7% | -11.9% | −20.8% | −27% / +44% |
| CMCOM.ASCM.com N.V. | 192.5 m | — | -22.2% | -1.5% | −5.4% | +23% / −30% |
1- and 3-year price returns: for PHIA.AS from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (EUR)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 15.59 Total return -41% · Per year -41% | 27.63 Total return 4% · Per year 4% | 41.70 Total return 56% · Per year 56% |
| 3 years | 13.80 Total return -43% · Per year -17% | 27.63 Total return 11% · Per year 3% | 45.99 Total return 80% · Per year 22% |
| 5 years | 12.21 Total return -45% · Per year -11% | 27.64 Total return 17% · Per year 3% | 50.71 Total return 107% · Per year 16% |
- Exit P/E± 6.91
- Net margin± 4.84
- Annual revenue growth± 4.15
- Annual dilution± 0.41
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202504 Mar 2026
- Annual report 202404 Mar 2025
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.